Rakovina Therapeutics Inc Financial Overview
Rakovina Therapeutics Inc's market cap is currently C$2.01M. The company's EPS TTM is C$-0.08; its P/E ratio is -0.17; Rakovina Therapeutics Inc is scheduled to report earnings on December 1, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
